Conversations powered by KPMG Luxembourg

Where pharma and funds converge | Part 1

26 min · 28. helmi 2025
jakson Where pharma and funds converge | Part 1 kansikuva

Kuvaus

In Part 1 of this two-episode special of Conversations powered by KPMG Luxembourg, we dive into the converging worlds of the funds industry and pharmaceuticals. Featuring Annick Breton (Partner, Head of Consulting at KPMG Luxembourg), this episode brings together Romain Labbé (Secretary General at the IML), Natasha Deloge (Head of the Innovation Division at the CSSF), Pierre Mottion (Head of DLT and Strategy/Investment Fund Services at Clearstream), and Matthias Van den Eede (Head of Digital Business Development & Beewise at Azimut Investments), as they discuss the common similarities and challenges affecting their industries. Part 1 of this topic delves into the issues surrounding ongoing consumer confidence and how it is affecting the pharmaceutical and investment funds ecosystems.

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity Conversations powered by KPMG Luxembourg-yhteisöön!

Aloita maksutta

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi. · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

10 jaksot

jakson Where pharma and funds converge | Part 1 kansikuva

Where pharma and funds converge | Part 1

In Part 1 of this two-episode special of Conversations powered by KPMG Luxembourg, we dive into the converging worlds of the funds industry and pharmaceuticals. Featuring Annick Breton (Partner, Head of Consulting at KPMG Luxembourg), this episode brings together Romain Labbé (Secretary General at the IML), Natasha Deloge (Head of the Innovation Division at the CSSF), Pierre Mottion (Head of DLT and Strategy/Investment Fund Services at Clearstream), and Matthias Van den Eede (Head of Digital Business Development & Beewise at Azimut Investments), as they discuss the common similarities and challenges affecting their industries. Part 1 of this topic delves into the issues surrounding ongoing consumer confidence and how it is affecting the pharmaceutical and investment funds ecosystems.

28. helmi 202526 min